Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro-platinum(II) treatment

Cancer Research

Volumn 65, Issue 12, 2005, Pages 4998-5002

  Shimura, Mari ^a   Saito, Akira ^d,f,g   Matsuyama, Satoshi ^d   Sakuma, Takahiro ^a   Terui, Yasuhito ^c   Ueno, Kazumasa ^d   Yumoto, Hirokatsu ^d   Yamauchi, Kazuto ^d   Yamamura, Kazuya ^d   Mimura, Hidekazu ^d   Sano, Yasuhisa ^d   Yabashi, Makina ^e   Tamasaku, Kenji ^f   Nishio, Kazuto ^b   Nishino, Yoshinori ^f   Endo, Katsuyoshi ^d   Hatake, Kiyohiko ^c   Mori, Yuzo ^d   Ishizaka, Yukihito ^a   Ishikawa, Tetsuya ^f  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e JAPAN SYNCHROTRON RADIATION RESEARCH INSTITUTE   (Japan)

^f SPring 8/Riken ^*  (Japan)

^g Japan Science and Technology Agency   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; CISPLATIN; GLUTATHIONE; ZINC;

ARTICLE; DEPLETION; DETOXIFICATION; DOWN REGULATION; DRUG RESISTANCE; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCANNING X RAY FLUORESCENCE MICROSCOPY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHELATING AGENTS; CISPLATIN; DRUG INTERACTIONS; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; METABOLIC DETOXICATION, DRUG; METALLOTHIONEIN; MICROSCOPY, FLUORESCENCE; PLATINUM; SPECTROMETRY, X-RAY EMISSION; ZINC;

EID: 20444451299     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0373     Document Type: Article

References (19)

1. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003;10:1663-82.
2. 99mtechnetium tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-I, and lung resistance-related protein expression. Nucl Med Biol 2003;30:627-32.
3. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 1992;89:3070-4.
4. Ishikawa T, Wright CD, Ishizuka H. GS-X pump is functionally overexpressed in cis-diamminedichlroroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 1994;269:29085-93.
5. Mayes PA. Nutrition. In: Murray RK, Granner DK, Mayers PA, Rodwell YW, editors. Harper's biochemistry. Chapter 54. 25th ed. New York: McGraw-Hill; 2000. p. 653-61.
6. Koropatnick J, Pearson J. Zinc treatment, metallothionein expression, and resistance to cisplatin in mouse melanoma cells. Somat Cell Mol Genet 1990;16: 529-37.
7. Katano K, Kondo A, Safaei R, et al. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 2002;62:6559-65.
8. Ilinski P, Lai B, Cai Z, et al. The direct mapping of the uptake of platinum anticancer agents in individual human ovarian adenocarcinoma cells using a hard X-ray microprobe. Cancer Res 2003;63:1776-9.
9. Hall MD, Dillon CT, Zhang M, et al. The cellular distribution and oxidation state of platinurn(II) and platinum(IV) antitumor complexes in cancer cells. J Biol Inorg Chem 2003;8:726-32.
10. Parat M-O, Richard M-J, Meplan C, Favir A, Béani J-C. Impairment of cultured cell proliferation and metallothionein expression by metal chelator NNN′ N′-tetrakis-(2-pyridylmethyl)ethylene diamine. Biol Trace Elem Res 1999;70:51-68.
11. Miao J, Hodgson KO, Ishikawa T, Larabell CA, LeGros MA, Nishino Y. Imaging whole Escherichia coli bacteria by using single-particle X-ray diffraction. Proc Natl Acad Sci U S A 2003;100:110-2.
12. Kirkpatrick P, Baez AV. Formation of optical images by X-rays. J Opt Soc Am 1948;38:766-74.
13. Yamauchi K, Yamamura K, Mimura H, et al. Two-dimensional submicron focusing of hard X-rays by two elliptical mirrors fabricated by plama chemical vaporization machining and elastic emission machining. Jpn J Appl Phys 2003;42:7129-34.
14. Kawamura-Akiyama Y, Kusaba H, Kanzawa F, Tamura T, Saijo N, Nishio K. Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines. Lung Cancer 2002;38:43-50.
15. Richarz AN, Wolf C, Bratter P. Determination of protein-bound trace elements in human cell cytosols of different organs and different pathological states. Analyst 2003;128:640-5.
16. Glantz SA. How to test for trends. In: Glantz SA, editors, Primer of biostatistics. Chapter 8. 2nd ed. New York: McGraw-Hill: 1987. p. 191-244.
17. Jourdan E, Jeanne KM, Régine S, Pascale G. Zinc-metallothinein genoprotective effect is independent of the glutathione depletion in HaCaT keratinocytes after solar light irradiation. J Cell Biochem 2004;92:631-40.
18. Parat M-O, Richard M-J, Béani J-C, Favier A. Involvement of zinc in intracellular oxidant/antioxidant balance. Biol Trace Elem Res 1997;60:187-204.
19. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RH, Hamilton TC. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 1993;53:5225-32.